Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.
作者信息
Goldstein D S, Williams M H
出版信息
Thorax. 1986 Jun;41(6):473-4. doi: 10.1136/thx.41.6.473.
Abstract
Serial measurements of vital capacity were obtained in 11 patients with impaired pulmonary function due to sarcoidosis during 12 courses of corticosteroid treatment. Vital capacity improved promptly and approached a maximum value in about three weeks. A three week trial is probably sufficient to show whether or not corticosteroids are effective in a patient with sarcoidosis.
摘要
相似文献
1
Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.
Thorax. 1986 Jun;41(6):473-4. doi: 10.1136/thx.41.6.473.
2
Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis.
Ann N Y Acad Sci. 1976;278:722-31. doi: 10.1111/j.1749-6632.1976.tb47087.x.
3
The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study.
Ann N Y Acad Sci. 1986;465:695-701. doi: 10.1111/j.1749-6632.1986.tb18548.x.
4
[Effect of prednisolone on the diffusion capacity of the lungs in sarcoidosis].
Klin Med (Mosk). 1974 Mar;52(3):115-20.
5
Lung and airway mechanics in early pulmonary sarcoidosis.
Bull Eur Physiopathol Respir. 1979 May-Jun;14(3):299-310.
6
Sarcoidosis: course and treatment.
Med Clin North Am. 1977 Nov;61(6):1267-78. doi: 10.1016/s0025-7125(16)31261-5.
7
A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
Johns Hopkins Med J. 1974 May;134(5):271-83.
8
Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal?
AJR Am J Roentgenol. 1990 Mar;154(3):481-5. doi: 10.2214/ajr.154.3.2106208.
9
Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis.
Eur Respir J. 1990 Apr;3(4):403-7.
10
[Pulmonary sarcoidosis and lung function (author's transl)].
Prax Pneumol. 1974 Feb;28(2):99-108.
引用本文的文献
1
A Prospective Review of the Results of Patients Treated and Followed up for a Diagnosis of Sarcoidosis.
Turk Thorac J. 2018 Jan;19(1):1-6. doi: 10.5152/TurkThoracJ.2017.17028. Epub 2017 Sep 27.
2
The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.
Thorax. 1999 Apr;54 Suppl 1(Suppl 1):S1-14. doi: 10.1136/thx.54.suppl_1.s1.
本文引用的文献
1
Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies.
Am J Med. 1966 Oct;41(4):541-51. doi: 10.1016/0002-9343(66)90216-6.
2
Long-term study of pulmonary sarcoidosis. The effect of steroid therapy as evaluated by pulmonary function studies.
J Chronic Dis. 1969 Jul;22(2):69-86. doi: 10.1016/0021-9681(69)90060-5.
3
A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
Johns Hopkins Med J. 1974 May;134(5):271-83.
4
Pulmonary function follow-up to 120 patients with sarcoidosis.
Ann N Y Acad Sci. 1976;278:301-7. doi: 10.1111/j.1749-6632.1976.tb47041.x.
5
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease.
Scand J Respir Dis. 1979 Aug;60(4):215-21.
Zotero 插件